Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
The American Journal of Geriatric Pharmacotherapy
|
March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly
Catherine I Starner, Sheila A Norman, Richard G Reynolds, et al.
Journal of Managed Care Pharmacy : JMCP
|
August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events
Catherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 18, 2025
AMCP real-world evidence standards: Overcoming barriers to using real-world evidence in US payer decision-making
Catherine M Lockhart, Elizabeth Powers, Brian Sweet, et al.
The American Journal of Managed Care
|
June 9, 2016
Sofosbuvir initial therapy abandonment and manufacturer coupons in a commercially insured population
Taruja D Karmarkar, Catherine I Starner, Yang Qiu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 16, 2019
Practical Next Steps in Improving Value Measurement and Use
Daniel A Ollendorf, Sachin Kamal-Bahl, Patrick P Gleason, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 27, 2026
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonists
Landon Z Marshall, Patrick P Gleason, Nicholas Friedlander, et al.
Journal of Managed Care Pharmacy : JMCP
|
February 7, 2013
Dalfampridine prior authorization program: a cohort study
Patrick P Gleason, Jill Phillips, Beckie A Fenrick, et al.
Journal of Managed Care Pharmacy : JMCP
|
October 7, 2009
Association of prescription abandonment with cost share for high-cost specialty pharmacy medications
Patrick P Gleason, Catherine I Starner, Brent W Gunderson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 16, 2019
Current Value Frameworks-What's New?
Richard J Willke, Richard H Chapman, Joshua J Seidman, et al.
Pharmacoepidemiology and Drug Safety
|
July 25, 2013
Impact of a drug utilization review program on high-risk use of prescription controlled substances
Matthew Daubresse, Patrick P Gleason, Yi Peng, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
The American Journal of Geriatric Pharmacotherapy
|
March 14, 2009
Effect of a retrospective drug utilization review on potentially inappropriate prescribing in the elderly
Catherine I Starner, Sheila A Norman, Richard G Reynolds, et al.
Journal of Managed Care Pharmacy : JMCP
|
August 13, 2008
Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events
Catherine I Starner, Jeremy A Schafer, Alan H Heaton, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 18, 2025
AMCP real-world evidence standards: Overcoming barriers to using real-world evidence in US payer decision-making
Catherine M Lockhart, Elizabeth Powers, Brian Sweet, et al.
The American Journal of Managed Care
|
June 9, 2016
Sofosbuvir initial therapy abandonment and manufacturer coupons in a commercially insured population
Taruja D Karmarkar, Catherine I Starner, Yang Qiu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 16, 2019
Practical Next Steps in Improving Value Measurement and Use
Daniel A Ollendorf, Sachin Kamal-Bahl, Patrick P Gleason, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 27, 2026
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonists
Landon Z Marshall, Patrick P Gleason, Nicholas Friedlander, et al.
Journal of Managed Care Pharmacy : JMCP
|
February 7, 2013
Dalfampridine prior authorization program: a cohort study
Patrick P Gleason, Jill Phillips, Beckie A Fenrick, et al.
Journal of Managed Care Pharmacy : JMCP
|
October 7, 2009
Association of prescription abandonment with cost share for high-cost specialty pharmacy medications
Patrick P Gleason, Catherine I Starner, Brent W Gunderson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 16, 2019
Current Value Frameworks-What's New?
Richard J Willke, Richard H Chapman, Joshua J Seidman, et al.
Pharmacoepidemiology and Drug Safety
|
July 25, 2013
Impact of a drug utilization review program on high-risk use of prescription controlled substances
Matthew Daubresse, Patrick P Gleason, Yi Peng, et al.
Page
of 4